c.bakker
TL2 Moderator · Basel
Contributes reviews on supplier material. Based in Basel.
Joined 9 January 2025 · last posted 2d
89 posts, newest first. Showing up to 150.
-
Revisiting: What pooling buys you and what it destroys Replied, post #107 · Evidence › Meta-analyses · 26 Jul 2026 · 24 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #91 · Wellbeing › Sleep · 21 Jul 2026 · 0 likes Worth separating two things that post #87 runs together. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months,…
-
What a certificate commits its issuer to Replied, post #59 · Analytics › COA interpretation · 19 Jul 2026 · 17 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #25 · Outcomes › Progress reports · 16 Jul 2026 · 5 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
What a reversed-phase purity number actually is Replied, post #49 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 19 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Publication patterns in the BPC-157 literature, examined Replied, post #30 · Compounds › Repair & healing peptides · 7 Jul 2026 · 0 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #94 · Compounds › Semaglutide · 7 Jul 2026 · 12 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #39 · Analytics › Method validation · 5 Jul 2026 · 1 like System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #28 · Compounds › Retatrutide · 30 Jun 2026 · 4 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #52 · Compounds › Secretagogues & GH axis · 27 Jun 2026 · 15 likes post #51 is right about the mechanism and I think understates the practical bit. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin…
-
Submitting a sample: the process end to end Replied, post #27 · Sourcing › Independent verification · 20 Jun 2026 · 1 like Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #34 · Access › Pricing · 15 Jun 2026 · 2 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
Racemisation and why it is invisible to a mass measurement Replied, post #30 · Analytics › Impurities & related substances · 10 Jun 2026 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Aggregates: multiples of the monomer mass. May not elute at all under a standard…
-
Revisiting: What pooling buys you and what it destroys Replied, post #42 · Evidence › Meta-analyses · 3 Jun 2026 · 3 likes Coming back to post #40, because the follow-up matters more than the original answer. Publication bias: what did not get published? Small studies with negative results…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #39 · Safety › Contraindications · 15 May 2026 · 9 likes Worth separating two things that post #35 runs together. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases…
-
Injection volume, overload, and peak distortion Replied, post #4 · Analytics › HPLC & UHPLC · 11 May 2026 · 27 likes I read the opening post twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post…
-
When a dose reduction is the correct response to a side effect Replied, post #19 · Practice › Dosing & titration · 10 May 2026 · 1 like The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Transporting a vial for a weekend away — a second dataset Replied, post #19 · Practice › Storage & stability · 2 Apr 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #21 · Analytics › Impurities & related substances · 28 Mar 2026 · 19 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #74 · Lounge › Introductions · 15 Mar 2026 · 21 likes Picking up post #71: that is the part I would want checked first. No judgment: people come to this community from all backgrounds and with all motivations.…
-
Which fields on a certificate actually matter, ranked Replied, post #4 · Analytics › COA interpretation · 10 Mar 2026 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #24 · Compounds › Repair & healing peptides · 10 Mar 2026 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #44 · Data & Tools › Calculators · 28 Feb 2026 · 11 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #37 · Compounds › Semaglutide · 27 Feb 2026 · 0 likes This follows post #34 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
Second pass at: Identical chromatograms across two different lots Replied, post #30 · Sourcing › Red flags · 27 Feb 2026 · 7 likes Coming back to post #28, because the follow-up matters more than the original answer. Inconsistency across documents: a certificate stating one purity, a website…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #24 · Practice › Administration · 26 Feb 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Measurement error in a self-reported exposure Replied, post #59 · Evidence › Study critique · 24 Feb 2026 · 24 likes Coming back to post #57, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #66 · Outcomes › Progress reports · 16 Feb 2026 · 0 likes Worth separating two things that post #62 runs together. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing…
-
IGF-1 as a surrogate endpoint and its limitations Replied, post #8 · Compounds › Secretagogues & GH axis · 16 Feb 2026 · 1 like This follows post #5 rather than contradicting it. Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative…
-
Citation sweep results: how many references did not say what was claimed Replied, post #40 · Meta › Wiki maintenance · 3 Feb 2026 · 30 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Why catalogue breadth is not evidence of anything Started this topic · Compounds › Other compounds · 21 Jan 2026 · 9 likes Why catalogue breadth is not evidence of anything I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 (…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #87 · Practice › Side effects · 13 Jan 2026 · 9 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #12 · Practice › Administration · 6 Jan 2026 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Filter needles: when they help and what they cost you Replied, post #19 · Devices › Syringes & needles · 5 Jan 2026 · 0 likes On post #15 — agreed on the reasoning, with one qualification. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm…
-
Prescription requirements and telehealth models Replied, post #93 · Sourcing › Regulatory · 26 Dec 2025 · 31 likes This follows post #90 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #49 · Analytics › Method validation · 22 Dec 2025 · 21 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #39 · Access › Pricing · 17 Dec 2025 · 5 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
Tracking that stops updating and then resumes — the long version Replied, post #51 · Sourcing › Logistics · 14 Dec 2025 · 0 likes This follows post #48 rather than contradicting it. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #17 · Compounds › Retatrutide · 3 Dec 2025 · 7 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #19 · Data & Tools › Calculators · 26 Nov 2025 · 18 likes post #18 answers the question as asked. The question underneath it is different. Dose equivalence calculator: compounds have different potencies. The calculator is…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #81 · Analytics › HPLC & UHPLC · 13 Nov 2025 · 2 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #2 · Analytics › HPLC & UHPLC · 11 Nov 2025 · 2 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #3 · Compounds › Oral incretins · 28 Oct 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading SURMOUNT-1 without the press release Replied, post #41 · Compounds › Tirzepatide · 22 Oct 2025 · 10 likes post #40 answers the question as asked. The question underneath it is different. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #9 · Compounds › Retatrutide · 12 Oct 2025 · 0 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #8 · Analytics › HPLC & UHPLC · 22 Sep 2025 · 21 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #119 · Data & Tools › Calculators · 17 Sep 2025 · 17 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #65 · Evidence › Study critique · 14 Sep 2025 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Titles that describe the question, not the situation — what changed since Replied, post #7 · Start Here › How to Ask · 10 Sep 2025 · 24 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
When a tidy document is a signal and when it is decoration — does this still hold? Replied, post #6 · Analytics › COA interpretation · 24 Aug 2025 · 4 likes Coming back to post #4, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Meeting a protein target on a suppressed appetite Replied, post #17 · Nutrition & Training › Protein & intake · 23 Aug 2025 · 0 likes This follows post #14 rather than contradicting it. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #31 · Practice › Storage & stability · 22 Aug 2025 · 18 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Hypertension improvement and when medication needs revisiting Replied, post #16 · Clinical › Comorbidities · 20 Aug 2025 · 3 likes Worth separating two things that post #12 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
When a preprint is the best available evidence and we say so Replied, post #55 · Evidence › Preprints · 14 Aug 2025 · 10 likes I read post #53 twice before replying, because I had assumed the opposite. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #83 · Compounds › Repair & healing peptides · 13 Aug 2025 · 2 likes post #82 is right about the mechanism and I think understates the practical bit. Stability of BPC-157 in solution: what has been measured in published work covers…
-
How to research a compound with no human data without deceiving yourself Replied, post #107 · Compounds › Other compounds · 4 Aug 2025 · 23 likes Worth separating two things that post #103 runs together. Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #59 · Evidence › Trials · 19 Jul 2025 · 0 likes On post #55 — agreed on the reasoning, with one qualification. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 12 likes On post #4 — agreed on the reasoning, with one qualification. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The…
-
Angle of injection and whether 90 degrees is always right Started this topic · Practice › Administration · 10 Jul 2025 · 8 likes On the subject in the title: Angle of injection and whether 90 degrees is always right Working notes rather than a conclusion. Reporting something rather than asking…
-
Repeatability versus intermediate precision Replied, post #121 · Analytics › Method validation · 2 Jul 2025 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #51 · Compounds › Repair & healing peptides · 26 Jun 2025 · 17 likes post #50 answers the question as asked. The question underneath it is different. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #41 · Compounds › Semaglutide · 25 Jun 2025 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #142 · Evidence › Journal club · 21 Jun 2025 · 10 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Reading an MS report that only gives you a single number Replied, post #110 · Analytics › Mass spectrometry · 17 Jun 2025 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #11 · Sourcing › Regulatory · 25 May 2025 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Which panel is worth repeating and which is worth ignoring Replied, post #12 · Clinical › Bloodwork · 2 May 2025 · 26 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #27 · Sourcing › Independent verification · 26 Apr 2025 · 2 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Dizziness on standing: the ordinary explanation first Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 24 Apr 2025 · 0 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #21 · Compounds › Oral incretins · 21 Apr 2025 · 17 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #56 · Clinical › Comorbidities · 12 Apr 2025 · 0 likes post #55 is right about the mechanism and I think understates the practical bit. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #58 · Analytics › Mass spectrometry · 6 Apr 2025 · 15 likes Resolution: "high resolution" commonly means
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #37 · Compounds › Secretagogues & GH axis · 5 Apr 2025 · 9 likes I read post #35 twice before replying, because I had assumed the opposite. GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms.…
-
Maintainer handover: how it works Replied, post #41 · Meta › Wiki maintenance · 16 Mar 2025 · 21 likes This follows post #38 rather than contradicting it. Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #56 · Evidence › Journal club · 14 Mar 2025 · 0 likes I read post #54 twice before replying, because I had assumed the opposite. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #12 · Access › Insurance & coverage · 11 Mar 2025 · 11 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #114 · Data & Tools › Calculators · 4 Mar 2025 · 17 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 27 Jan 2025 · 0 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #138 · Compounds › Tirzepatide · 9 Jan 2025 · 2 likes Picking up post #135: that is the part I would want checked first. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #148 · Analytics › COA interpretation · 11 Dec 2024 · 21 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Revisiting: Moderation log format change Replied, post #55 · Meta › Announcements · 5 Dec 2024 · 11 likes post #54 is right about the mechanism and I think understates the practical bit. Implementation timeline: announcements include when a change takes effect. Marking the…
-
Identical chromatograms across two different lots Replied, post #49 · Sourcing › Red flags · 14 Nov 2024 · 0 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Time to steady state after a dose increase Replied, post #108 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 5 likes post #107 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #23 · Pharmacology › Formulation chemistry · 27 Oct 2024 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Progressive overload when the scale is falling — one year on Replied, post #112 · Nutrition & Training › Resistance training · 1 Oct 2024 · 0 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #24 · Clinical › Bloodwork · 12 Sep 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #14 · Clinical › Special populations · 3 Sep 2024 · 7 likes Coming back to post #12, because the follow-up matters more than the original answer. Adolescents: a distinct evidence base exists. The compounds are not approved for…
-
Correlation in a self-tracked dataset: what it can support Replied, post #85 · Research Methods › Statistics · 23 Aug 2024 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #4 · Sourcing › Independent verification · 17 Aug 2024 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #30 · Analytics › COA interpretation · 10 Aug 2024 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…